Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Total Current Liabilities: 2018-2025

Historic Total Current Liabilities for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to $31.7 million.

  • Arcturus Therapeutics Holdings' Total Current Liabilities fell 54.37% to $31.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year decrease of 54.37%. This contributed to the annual value of $65.5 million for FY2024, which is 20.12% down from last year.
  • Latest data reveals that Arcturus Therapeutics Holdings reported Total Current Liabilities of $31.7 million as of Q3 2025, which was down 31.85% from $46.5 million recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Total Current Liabilities registered a high of $127.0 million during Q4 2022, and its lowest value of $31.7 million during Q3 2025.
  • Moreover, its 3-year median value for Total Current Liabilities was $82.0 million (2023), whereas its average is $74.5 million.
  • As far as peak fluctuations go, Arcturus Therapeutics Holdings' Total Current Liabilities soared by 322.07% in 2021, and later slumped by 57.20% in 2025.
  • Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' Total Current Liabilities stood at $99.5 million in 2021, then climbed by 27.57% to $127.0 million in 2022, then crashed by 35.43% to $82.0 million in 2023, then dropped by 20.12% to $65.5 million in 2024, then plummeted by 54.37% to $31.7 million in 2025.
  • Its Total Current Liabilities stands at $31.7 million for Q3 2025, versus $46.5 million for Q2 2025 and $49.4 million for Q1 2025.